General Info
argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer.
Location: Boston
Country:
Industries:
Investment Regions:
Investment Stages: late-stage, pre-seed, seed, series-a
Website: https://www.argenx.com/
vc
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: not-active
AI Reasoning: Search results show argenx is primarily an immunology biopharma company and not a venture investor; recent activity relates to partnerships and deals (e.g., Unnatural Products deal, investments in internal Immunology Innovation Program) with latest items in 2025. I found no evidence of argenx making startup investments within the past 12 months; the available items are corporate deals/partnerships rather than venture investments in startups. Therefore classify as not-active.
Here are the thresholds established for the different statuses:
Not Active – No known investments in the last 12 months.
Low Activity – Only known investments between the last 12 and 6 months.
Active – Known investments between the last 6 and 3 months.
Very Active – Known investments in the last 3 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of argenx
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI